Janos L. Tanyi of the Perelman School of Medicine spoke about a large-scale trial of Cytalux, which makes cancer cells glow during surgery, being conducted at the Abramson Cancer Center. “Those patients who have all the visible cancerous lesions removed have the best survival rates,” he said.
https://www.inquirer.com/health/ovarian-cancer-treatment-cytalux-fda-20220105.html Philadelphia Inquirer